November 18, 2024 – Singapore – EpiMedtech Global, a leader in genetic and epigenetic testing, is proud to announce that
Singapore, November 18 2024 — EpiMedTech Global Singapore is thrilled to announce the successful validation of our groundbreaking Epicervix HPV
FOR IMMEDIATE RELEASE Singapore – October 31, 2024 – Epi Med Tech Global, a pioneer in genetic and epigenetic testing,
FOR IMMEDIATE RELEASE Revolutionizing the early detection of health risks through cutting-edge DNA methylation and genetic analysis. Singapore, 2024-10-30 –
EpiMedTech Global, a biotech company developing early disease detection tests, announced today the validation of its new test for early
Microarray Technology Microarrays are commonly used to study DNA methylation. These small chips contain many probes that attach to
Is Epigenetic Entropy and Its Role in Aging Possible to Extend Life? Scientists have been trying for a long time
Singapore – News File Corp. – August 27, 2024 – EpiMedTech Global, a company focused on revolutionizing healthcare through real-world
EpiMedTech Global Featured in Coverage of NIBA’s 150th Investment Conference EpiMedTech Global, a pioneering company dedicated to transforming healthcare through
A vegan diet may slow down the ticking of your biological clock. Recent research indicates that twins, one following a
EpiMedTechGlobal (EMTG)
60 Paya Lebar Road,
#08-06 Paya Lebar Square
Singapore 409051
Honk Kong Lab
Unit 313-315, 3/F Biotech Centre 2
11 Science Park West Avenue
Hong Kong Science Park
US Epitherapeutics
1829 Reisterstown Rd, Suite: 350
Baltimore, MD 21208
+1 (443) 256 5179
MTL Epitherapeutics
600 – 2000 AV McGill College Montreal, QC CA H3A3H3
+1 (514) 448 2185
Shenzhen Lab
Zone E, Floor 4, Building E, Gangzhilong Business Center,
Qinglong Road, Longhua District, Shenzhen
Hong Kong: +(852) 60725262 USA: +1 (443) 256 5179 Canada: +1 (514) 448 2185
Founded in 2016 by Prof. Moshe Szyf, a global pioneer in the dynamic and rapidly evolving field of epigenetics, EpiMedTechGlobal (EMTG) stands as a force driving innovation. Officially headquartered in Singapore, our organization directs a state-of-the-art research and diagnostic lab located in Hong Kong, which serves as the epicenter of our groundbreaking endeavors. Here, our dedicated scientists are committed to driving innovation in epigenetics and the early detection of diseases. At EMTG, it’s not just about detecting diseases; it’s about unlocking and offering solutions that promote longevity through the hidden stories in our DNA.
©2023, EpiMedTechGlobal. All Rights Reserved.
